“The Role of Serum Level of Indoleamine 2,3–dioxygenase 1 (IDO1) in Patients with Prostate Cancer”, MLU, vol. 21, no. 2, pp. 1402–1407, Mar. 2021, doi: 10.37506/mlu.v21i2.2888.